Navamedic ASA Valuation
| NAVA Stock | NOK 24.70 0.70 2.92% |
At this time, the firm appears to be undervalued. Navamedic ASA secures a last-minute Real Value of 26.03 per share. The latest price of the firm is 24.7. Our model forecasts the value of Navamedic ASA from analyzing the firm fundamentals such as Return On Equity of 0.073, current valuation of 578.31 M, and Profit Margin of 0.03 % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Navamedic ASA's price fluctuation is not too volatile at this time. Calculation of the real value of Navamedic ASA is based on 3 months time horizon. Increasing Navamedic ASA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Navamedic stock is determined by what a typical buyer is willing to pay for full or partial control of Navamedic ASA. Since Navamedic ASA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Navamedic Stock. However, Navamedic ASA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 24.7 | Real 26.03 | Hype 24.7 | Naive 21.77 |
The intrinsic value of Navamedic ASA's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Navamedic ASA's stock price.
Estimating the potential upside or downside of Navamedic ASA helps investors to forecast how Navamedic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Navamedic ASA more accurately as focusing exclusively on Navamedic ASA's fundamentals will not take into account other important factors: Navamedic ASA Total Value Analysis
Navamedic ASA is now expected to have takeover price of 578.31 M with market capitalization of 539.41 M, debt of 44.8 M, and cash on hands of 52.62 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Navamedic ASA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
578.31 M | 539.41 M | 44.8 M | 52.62 M |
Navamedic ASA Investor Information
About 42.0% of the company outstanding shares are owned by corporate insiders. The book value of Navamedic ASA was now reported as 9.25. The company last dividend was issued on the 13th of April 2010. Navamedic ASA had 663:662 split on the 19th of February 2020. Based on the key measurements obtained from Navamedic ASA's financial statements, Navamedic ASA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Navamedic ASA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Navamedic ASA has an asset utilization ratio of 84.33 percent. This suggests that the Company is making 0.84 for each dollar of assets. An increasing asset utilization means that Navamedic ASA is more efficient with each dollar of assets it utilizes for everyday operations.Navamedic ASA Ownership Allocation
Navamedic ASA maintains a total of 16.35 Million outstanding shares. Navamedic ASA holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Navamedic ASA Profitability Analysis
The company reported the revenue of 278.44 M. Net Income was 2.36 M with profit before overhead, payroll, taxes, and interest of 111.74 M.About Navamedic ASA Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Navamedic ASA. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Navamedic ASA based exclusively on its fundamental and basic technical indicators. By analyzing Navamedic ASA's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Navamedic ASA's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Navamedic ASA. We calculate exposure to Navamedic ASA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Navamedic ASA's related companies.Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway. NAVAMEDIC ASA operates under Healthcare Products classification in Norway and is traded on Oslo Stock Exchange. It employs 26 people.
8 Steps to conduct Navamedic ASA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Navamedic ASA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Navamedic ASA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Navamedic ASA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Navamedic ASA's revenue streams: Identify Navamedic ASA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Navamedic ASA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Navamedic ASA's growth potential: Evaluate Navamedic ASA's management, business model, and growth potential.
- Determine Navamedic ASA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Navamedic ASA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Navamedic Stock
Navamedic ASA financial ratios help investors to determine whether Navamedic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Navamedic with respect to the benefits of owning Navamedic ASA security.